Jeffrey Wager

Q: What is Jeffrey Wager email address?

Email Jeffrey Wager at jeff.wager@enbiotix.com. This email is the most updated Jeffrey Wager email found in 2026.

Q: How to contact Jeffrey Wager?

To contact Jeffrey Wager send an email to jeff.wager@enbiotix.com. If you want to call Jeffrey Wager try calling on +13212438119 and +13218023142.

Founder & Managing Director at Apeiron Partners LLC | Boston, Massachusetts, United States

About Jeffrey Wager

Jeffrey Wager is a seasoned executive and the Founder & Managing Director of Apeiron Partners LLC, where he leverages his extensive expertise in the life sciences and biopharmaceutical sectors to drive innovation and growth. With a robust background that spans company formation, venture capital, and corporate development, Jeffrey has played a pivotal role in the establishment and scaling of over 40 companies, navigating complex transactions and financings that have shaped the landscape of emerging markets. His strategic vision and leadership have been instrumental in guiding organizations through critical phases of development, particularly in the realms of biotechnology and pharmaceuticals.

At Apeiron Partners, Jeffrey focuses on identifying and nurturing high-potential opportunities within the rare disease and oncology spaces, aligning with his commitment to addressing unmet medical needs. His involvement with Spexis AG, a Swiss-listed company specializing in chronic respiratory diseases, exemplifies his dedication to advancing innovative therapies. Under his guidance, Apeiron Partners has engaged in significant projects that emphasize technology transfer and clinical development, ensuring that groundbreaking research translates into viable treatments.

Jeffrey's multifaceted skill set encompasses investment banking and mergers, enabling him to adeptly navigate the complexities of the life sciences ecosystem. His insights into venture capital dynamics and start-up growth strategies position him as a thought leader in the industry, making him a sought-after advisor for emerging companies looking to make their mark. As he continues to champion transformative initiatives at Apeiron Partners, Jeffrey Wager remains committed to fostering advancements that enhance patient outcomes and drive the future of healthcare.

Jeffrey Wager Work